IPRATECH/ IPRASENSE

IPRATECH delivers standard and custom-engineered control solutions across upstream and downstream bioprocesses, as well as mRNA and radioisotope manufacturing. Backed by deep pharma R&D expertise and proprietary in-house technologies, we accelerate the path from proof-of-concept to prototype up to cGMP-industrialized equipment, supporting biotech start-ups, pharma leaders, CDMOs, and equipment manufacturers (OEMs).

IPRASENSE offers advanced technologies for cell counting and viability analysis, empowering biopharmaceutical manufacturers and research institutions to make critical bioprocess decisions with speed, precision, and confidence. Our NORMA and CYTONOTE platforms deliver reproducible results in seconds, meeting the highest standards of scientific rigor and regulatory compliance, including 21 CFR Part 11. From early-stage research to GMP production, we partner with our customers to ensure our technology integrates seamlessly into their workflows, because we believe that reliable measurement should never be a barrier to therapeutic innovation.